-
EP4074735
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4074735
| EP4074735 - CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 21.07.2023 Database last updated on 24.07.2024 | |
| Former | Request for examination was made Status updated on 07.04.2023 | ||
| Former | The application has been published Status updated on 16.09.2022 | Most recent event Tooltip | 17.11.2023 | Change - inventor | published on 20.12.2023 [2023/51] | Applicant(s) | For all designated states BioAtla, Inc. 11085 Torreyana Road, Suite 100 San Diego, CA 92121 / US | [2022/42] | Inventor(s) | 01 /
Short, Jay M. Jackson, Wyoming 83001 / US | [2023/51] |
| Former [2022/42] | 01 /
Short, Jay M. Del Mar, CA 92014 / US | Representative(s) | De Vries & Metman Overschiestraat 180 1062 XK Amsterdam / NL | [2022/42] | Application number, filing date | 22164162.4 | 27.08.2015 | [2022/42] | Priority number, date | US201462043067P | 28.08.2014 Original published format: US 201462043067 P | [2022/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4074735 | Date: | 19.10.2022 | Language: | EN | [2022/42] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 15.09.2022 | Classification | IPC: | C07K19/00, C07K14/705, C07K16/46, C12N5/0783, A61K35/17, A61K38/16, A61K39/395, A61P35/00, // A61K38/00, C07K14/725, C07K14/735, C07K16/18, A61K39/00 | [2022/42] | CPC: |
C07K16/18 (EP,US);
A61P35/00 (EP,KR,RU);
C07K14/7051 (EP,KR,US);
C12N15/1058 (RU,US);
A61K39/395 (RU);
A61K39/3955 (US);
A61K39/39558 (US);
A61K39/4611 (EP,KR,RU);
A61K39/4631 (EP,KR,RU);
A61K39/4644 (EP,RU);
A61K39/464403 (KR);
A61P35/02 (EP);
A61P35/04 (EP);
C07K14/705 (EP,RU,US);
C07K14/70503 (EP,US);
C07K14/70521 (EP,US);
C07K14/70535 (EP,US);
C07K16/28 (US);
C07K16/2863 (KR,US);
C07K19/00 (RU);
C12N15/102 (US);
C12N5/0636 (KR);
A61K2039/5156 (US);
A61K2039/572 (US);
A61K35/17 (US);
A61K38/00 (EP,US);
C07K2317/31 (US);
C07K2317/622 (EP,KR,US);
C07K2317/92 (US);
C07K2317/94 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/19] |
| Former [2022/42] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | BEDINGT AKTIVE CHIMÄRE ANTIGENREZEPTOREN FÜR MODIFIZIERTE T-ZELLEN | [2022/42] | English: | CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS | [2022/42] | French: | RÉCEPTEURS D'ANTIGÈNE CHIMÉRIQUE CONDITIONNELLEMENT ACTIFS POUR CELLULES T MODIFIÉES | [2022/42] | Examination procedure | 31.03.2023 | Examination requested [2023/19] | 31.03.2023 | Date on which the examining division has become responsible | 21.07.2023 | Despatch of a communication from the examining division (Time limit: M04) | 14.11.2023 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP15836397.8 / EP3186284 | Fees paid | Renewal fee | 24.03.2022 | Renewal fee patent year 03 | 24.03.2022 | Renewal fee patent year 04 | 24.03.2022 | Renewal fee patent year 05 | 24.03.2022 | Renewal fee patent year 06 | 24.03.2022 | Renewal fee patent year 07 | 29.08.2022 | Renewal fee patent year 08 | 28.08.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2012031744 (CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT [DE], et al) [A] 1-17 * the whole document *; | [A]WO2012156747 (UCL BUSINESS PLC [GB], et al) [A] 1-17 * the whole document *; | [A]WO2013126733 (UNIV PENNSYLVANIA [US]) [A] 1-17 * the whole document *; | [A]WO2014011993 (UNIV PENNSYLVANIA [US]) [A] 1-17* the whole document * | by applicant | US195 | US4683 | US4676980 | US4704362 | GB2200651 | US4777127 | US4797368 | EP0345242 | WO9007936 | US4946778 | WO9102805 | US5139941 | US5143854 | WO9303769 | WO9308829 | WO9310218 | WO9311230 | US5219740 | WO9319191 | WO9322429 | WO9325698 | WO9325234 | WO9403622 | WO9412649 | WO9428938 | WO9500655 | WO9511984 | US5434049 | WO9617958 | US5556752 | US5632957 | US5641870 | WO9746313 | US5700637 | US5731168 | US5744305 | US5770456 | US5800992 | US5807522 | US5830645 | US5856174 | US5858358 | WO9909217 | US5883223 | US5959098 | US5965452 | WO9951773 | US5994136 | US6013440 | US6013516 | US6022963 | US6045996 | US6048695 | US6054270 | US6258606 | US6261776 | US2001008765 | US2001012537 | US2001014449 | US2001014448 | US6277628 | US6277489 | US2001016322 | US2001018642 | US2001019827 | US2002004587 | US6352694 | US6534055 | US6692964 | US6797514 | US6867041 | US6887466 | US6905680 | US6905681 | US6905874 | US2006025576 | US2006121005 | US7067318 | US7144575 | US7172869 | US7175843 | US2007111260 | US7232566 | US2009130718 | US2009136950 | WO2009089004 | WO2011109726 | WO2011157905 | US2012171120 | US2013280220 | WO2013170168 | - HECZEY et al., "Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy", Blood, (20140000), vol. 124, doi:10.1182/blood-2013-11-541235, pages 2824 - 2833, XP055467113 DOI: http://dx.doi.org/10.1182/blood-2013-11-541235 | - ZHEN et al., "HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells", Mol Ther., (20150000), vol. 23, doi:10.1038/mt.2015.102, pages 1358 - 1367, XP055508957 DOI: http://dx.doi.org/10.1038/mt.2015.102 | - THEMELI et al., "New cell sources for T cell engineering and adoptive immunotherapy", Cell Stem Cell, (20150000), vol. 16, doi:10.1016/j.stem.2015.03.011, pages 357 - 366, XP055185149 DOI: http://dx.doi.org/10.1016/j.stem.2015.03.011 | - THEMELI et al., "Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy", Nat Biotechnol., (20130000), vol. 31, doi:10.1038/nbt.2678, pages 928 - 933, XP055485171 DOI: http://dx.doi.org/10.1038/nbt.2678 | - MOSER et al., "Endothelial cell surface Fl-FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin", Proc Natl Acad Sci U S A, (20010000), vol. 98, pages 6656 - 01 | - "The Immunoglobulin Gene Superfamily", A. F. WILLIAMSA. N. BARCLAY, Molecular Cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, (19890000), pages 361 - 368 | - AKAMATSUU et al., J. Immunol. Methods, (20070000), vol. 327, pages 40 - 52 | - HO et al., "Isolation of anti-CD22 Fv with high affinity by Fv display on human cells", Proc Natl Acad Sci USA, (20060000), vol. 103, pages 9637 - 9642 | - BEERLI et al., "Isolation of human monoclonal antibodies by mammalian cell display", Proc Natl Acad Sci USA, (20080000), vol. 105, doi:10.1073/PNAS.0805942105, pages 14336 - 14341, XP002518752 DOI: http://dx.doi.org/10.1073/PNAS.0805942105 | - KONDOUEDA, "Yeast cell-surface display-applications of molecular display", Appl. Microbiol. Biotechnol., (20040000), vol. 64, pages 28 - 40 | - LEE et al., "Microbial cell-surface display", TRENDS in Bitechnol., (20030000), vol. 21, doi:10.1016/S0167-7799(02)00006-9, pages 45 - 52, XP004397636 DOI: http://dx.doi.org/10.1016/S0167-7799(02)00006-9 | - BODERWITTRUP, "Yeast surface display for screening combinatorial polypeptide libraries", Nature Biotechnol., (19970000), vol. 15, page 553 | - MAHER, "Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells", ISRN Oncology, (20120000), vol. 2012, no. 278093 | - CHAUDHARY et al., "A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin", Proc. Natl. Acad. Sci., (19900000), vol. 87, page 9491 | - BEDZYK et al., "Immunological and structural characterization of a high affinity anti-fluorescein single-chain antibody", J. Biol. Chem., (19900000), vol. 265, page 18615 | - XIONG et al., "Development of tumor targeting anti-MUC-1 multimer: effects of di-scFv unpaired cysteine location on PEGylation and tumor binding", Protein Engineering Design and Selection, (20060000), vol. 19, doi:10.1093/protein/gzl020, pages 359 - 367, XP009147927 DOI: http://dx.doi.org/10.1093/protein/gzl020 | - KUFER et al., "A revival of bispecific antibodies", Trends in Biotechnology, (20040000), vol. 22, doi:10.1016/j.tibtech.2004.03.006, pages 238 - 244, XP004504363 DOI: http://dx.doi.org/10.1016/j.tibtech.2004.03.006 | - ROTHE, A. et al., "A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma", Blood, (20150625), vol. 125, no. 26, doi:10.1182/blood-2014-12-614636, pages 4024 - 4031, XP055218341 DOI: http://dx.doi.org/10.1182/blood-2014-12-614636 | - PARK et al., "Are all chimeric antigen receptors created equal?", J Clin Oncol., (20150000), vol. 33, pages 651 - 653, XP008179075 | - HERMANSON et al., "Utilizing chimeric antigen receptors to direct natural killer cell activity", Front Immunol., (20150000), vol. 6, page 195 | - ZHANG et al., "An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo", J Immunol., (20120000), vol. 189, doi:10.4049/jimmunol.1103495, pages 2290 - 2299, XP055066131 DOI: http://dx.doi.org/10.4049/jimmunol.1103495 | - TOPFER et al., "DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy", J Immunol., (20150000), vol. 194, doi:10.4049/jimmunol.1400330, pages 3201 - 3212, XP055439156 DOI: http://dx.doi.org/10.4049/jimmunol.1400330 | - GILLIS et al., "Contribution of Human FcyRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies", Front Immunol., (20140000), vol. 5, page 254 | - BRENNAN et al., Science, (19850000), vol. 229, pages 81 - 96 | - "Methods In Enzymnology", R. I. FRESHNEY, Immunochemical Methods In Cell And Molecular Biology, Cold Spring Harbor Laboratory, (19870000), vol. 154,155 | - ECKERDAVIS, "Inhibition of gene expression in plant cells by expression of antisense RNA", Proc Natl Acad Sci USA, (19860000), vol. 1-IV, pages 5372 - 5376 | - LIAO, Gene, (19900000), vol. 88, pages 107 - 111 | - Science, (19880000), vol. 241, no. 4861, pages 53 - 57 | - QUEEN et al., Immunol. Rev., (19860000), vol. 89, page e 49 | - TRAUNECKER et al., EMBO J., (19910000), vol. 10, page 3655 | - KOHLER, "Continuous cultures of fused cells secreting antibody of predefined specificity", Nature, (19750000), vol. 256, doi:10.1038/256495a0, page 495, XP037052082 DOI: http://dx.doi.org/10.1038/256495a0 | - HOOGENBOOM, "Designing and optimizing library selection strategies for generating high-affinity antibodies", Trends Biotechnol., (19970000), vol. 15, doi:10.1016/S0167-7799(97)84205-9, pages 62 - 70, XP000669466 DOI: http://dx.doi.org/10.1016/S0167-7799(97)84205-9 | - KATZ, "Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display", Annu. Rev. Biophys. Biomol. Struct., (19970000), vol. 26, pages 27 - 45 | - JOHNSTON, "Gene chips: Array of hope for understanding gene regulation", Curr. Biol., (19980000), vol. 8, doi:10.1016/S0960-9822(98)70103-4, pages R171 - R174, XP000905195 DOI: http://dx.doi.org/10.1016/S0960-9822(98)70103-4 | - SCHUMMER, "Inexpensive Handheld Device for the Construction of High-Density Nucleic Acid Arrays", Biotechniques, (19970000), vol. 23, pages 1087 - 1092, XP002085222 | - KERN, "Direct hybridization of large-insert genomic clones on high-density gridded cDNA filter arrays", Biotechniques, (19970000), vol. 23, pages 120 - 124, XP002205835 | - SOLINAS-TOLDO, "Matrix-Based Comparative Genomic Hybridization: Biochips to Screen for Genomic Imbalances", Genes, Chromosomes & Cancer, (19970000), vol. 20, doi:10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I, pages 399 - 407, XP001024611 DOI: http://dx.doi.org/10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I | - BOWTELL, "Options Available-From Start to Finish-for Obtaining Expression Data by Microarray", Nature Genetics Supp., (19990000), vol. 21, doi:10.1038/4455, pages 25 - 32, XP000865983 DOI: http://dx.doi.org/10.1038/4455 | - ZAPATA et al., Protein Eng., (19950000), vol. 8, pages 1057 - 1062 | - OLAFSEN et al., Protein Eng. Design & Sel., (20040000), vol. 17, pages 315 - 323 | - MILSTEINCUELLO, Nature, (19830000), vol. 305, page 537 | - KOSTELNY et al., J. Immunol., (19920000), vol. 148, pages 1547 - 1553 | - HOLLINGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448 | - GRUBER et al., J. Immunol., (19940000), vol. 152, page 5368 | - TUTT et al., J. Immunol., (19910000), vol. 147, page 60 | - WU et al., Nature Biotechnology, (20070000), vol. 25, pages 1290 - 1297 | - LOUVEAU, A. et al., "Structural and functional features of central nervous system lymphatic vessels", Nature, (20150716), vol. 523, doi:10.1038/nature14432, pages 337 - 341, XP055445074 DOI: http://dx.doi.org/10.1038/nature14432 | - BLAGOSKLONNY, "Antiangiogenic therapy and tumor progression", Cancer Cell, (20040000), vol. 5, pages 16,33 - 17 | - REDZIC, "Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences", Fluids and Barriers of the CNS, (20110000), vol. 8, doi:10.1186/2045-8118-8-3, page 3, XP021091548 DOI: http://dx.doi.org/10.1186/2045-8118-8-3 | - ABI-SAAB et al., "Striking Differences in Glucose and Lactate Levels Between Brain Extracellular Fluid and Plasma in Conscious Human Subjects: Effects of Hyperglycemia and Hypoglycemia", Journal of Cerebral Blood Flow & Metabolism, (20020000), vol. 22, pages 271 - 279 | - JEBENS et al., "On the viscosity and pH of synovial fluid and the pH of blood", The Journal of Bone and Joint Surgery, (19590000), vol. 41 B, pages 388 - 400 | - FARR et al., "Significance of the hydrogen ion concentration in synovial fluid in Rheumatoid Arthritis", Clinical and Experimental Rheumatology, (19850000), vol. 3, pages 99 - 104 | - FERNANDES et al., "The Role of Cytokines in Osteoarthritis Pathophysiology", Biorheology, (20020000), vol. 39, pages 237 - 246, XP008009498 | - SWARTS et al., "Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy", Cancer Res, (20120000), vol. 72, pages 2473 - 2480 | - WEBER et al., "The tumor microenvironment", Surgical Oncology, (20120000), vol. 21, pages 172 - 177 | - ESTRELLA et al., "Acidity Generated by the Tumor Microenvironment Drives Local Invasion", Cancer Research, (20130000), vol. 73, doi:10.1158/0008-5472.CAN-12-2796, pages 1524 - 1535, XP055620422 DOI: http://dx.doi.org/10.1158/0008-5472.CAN-12-2796 | - LORUSSO et al., "The tumor microenvironment and its contribution to tumor evolution toward metastasis", Histochem Cell Biol, (20080000), vol. 130, doi:10.1007/s00418-008-0530-8, pages 1091 - 1103, XP019657787 DOI: http://dx.doi.org/10.1007/s00418-008-0530-8 | - SCOTT et al., "Antibody therapy of cancer", Nature Reviews Cancer, (20120000), vol. 12, doi:10.1038/nrc3236, pages 278 - 287, XP055531673 DOI: http://dx.doi.org/10.1038/nrc3236 | - PARDOLL, Nature Reviews Cancer, (20120000), vol. 12, pages 252 - 264 | - NIRSCHLDRAKE, Clin Cancer Res, (20130000), vol. 19, pages 4917 - 4924 | - FONG et al., Cancer Res., (20090000), vol. 69, no. 2, pages 609 - 615 | - WEBER, Cancer Immunol. Immunother, (20090000), vol. 58, pages 823 - 830 | - SCADDEN, "The stem-cell niche as an entity of action", Nature, (20060000), vol. 441, doi:10.1038/nature04957, pages 1075 - 1079, XP055006402 DOI: http://dx.doi.org/10.1038/nature04957 | - DRUMMOND-BARBOSA, "Stem Cells, Their Niches and the Systemic Environment: An Aging Network", Genetics, (20080000), vol. 180, pages 1787 - 1797 | - FUCHS, "Socializing with the Neighbors: Stem Cells and Their Niche", Cell, (20040000), vol. 116, pages 769 - 778 | - KEITH et al., "Hypoxia-Inducible Factors, Stem Cells, and Cancer", Cell, (20070000), vol. 129, doi:10.1016/J.CELL.2007.04.019, pages 465 - 472, XP002613546 DOI: http://dx.doi.org/10.1016/J.CELL.2007.04.019 | - MOHYELDIN et al., "Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche", Cell Stem Cell, (20100000), vol. 7, doi:10.1016/j.stem.2010.07.007, pages 150 - 161, XP055035700 DOI: http://dx.doi.org/10.1016/j.stem.2010.07.007 | - XIE et al., "Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells", Proc Natl Acad Sci U S A, (20130000), vol. 110, doi:10.1073/pnas.1306263110, pages 8099 - 8104, XP055565668 DOI: http://dx.doi.org/10.1073/pnas.1306263110 | - MELIDONI et al., "Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells", Proc Natl Acad Sci USA, (20130000), vol. 110, pages 17802 - 17807 | - LENTZ, "The reognition event between virus and host cell receptor: a target for antiviral agents", J. of Gen. Virol., (19900000), vol. 71, pages 751 - 765 | - MALI et al., "Cas9 as a versatile tool for engineering biology", Nature Methods, (20130000), vol. 10, doi:10.1038/nmeth.2649, pages 957 - 963, XP002718606 DOI: http://dx.doi.org/10.1038/nmeth.2649 | - MAKAROVA et al., "Evolution and classification of the CRISPR-Cas systems", Nature Reviews Microbiology, (20110000), vol. 9, doi:10.1038/nrmicro2577, pages 467 - 477, XP009155547 DOI: http://dx.doi.org/10.1038/nrmicro2577 | - CARDONE et al., "The role of disturbed pH dynamics and the Na(+)/H(+) exchanger in metatasis", Nat. Rev. Cancer, (20050000), vol. 5, pages 786 - 795 | - RIOS et al., "Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells", American Journal of Physiology - Lung Cellular and Molecular Physiology, (20050000), vol. 289, pages L867 - L874 | - HAQBERG, "Intracellular pH during ischemia in skeletal muscle: relationship to membrane potential, extracellular pH, tissue lactic acid and ATP", Pflugers Arch., (19850000), vol. 404, pages 342 - 347 | - HAN et al., "Fluorescent Indicators for Intracellular pH", Chem Rev., (20100000), vol. 110, doi:10.1021/cr900249z, pages 2709 - 2728, XP055078676 DOI: http://dx.doi.org/10.1021/cr900249z | - GRUNHAUSHORWITZ, "Adenoviruses as cloning vectors", Seminars Virol., (19920000), vol. 3, pages 237 - 252, XP008041978 | - BERGER et al., "Adoptive transfer of virus-specific and tumor-specific T cell immunity", Curr. Opin. Immunol., (20090000), vol. 21, doi:10.1016/j.coi.2009.02.010, pages 224 - 232, XP026058400 DOI: http://dx.doi.org/10.1016/j.coi.2009.02.010 | - BERG et al., Transplant Proc., (19980000), vol. 30, no. 8, pages 3975 - 3977 | - HAANEN et al., J. Exp. Med., (19990000), vol. 190, no. 9, page 13191328 | - GARLAND et al., J. Immunol. Meth., (19990000), vol. 227, no. 1-2, pages 53 - 63 | - CHIPIZZO, "Angiosatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase", Cancer Res., (20060000), vol. 66, no. 2, pages 875 - 882 | - MOSER et al., "Angiostatin binds ATP synthase on the surface of human endothelial cells", Proc Natl Acad Sci USA, (19990000), vol. 96, doi:10.1073/pnas.96.6.2811, pages 2811 - 6, XP002153176 DOI: http://dx.doi.org/10.1073/pnas.96.6.2811 | - GRANT et al., "Matrigel induces thymosin h 4 gene in differentiating endothelial cells", J Cell Sci, (19950000), vol. 108, pages 3685 - 94, XP002441697 | - WAHL MLGRANT DS, "Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH", Gen Pharmacol, (20020000), vol. 35, pages 277 - 85 |